RKDA (Arcadia Biosciences) Cyclically Adjusted FCF per Share: $-130.59 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

RKDA Arcadia Biosciences Inc RKDA
43 GF Score
Price $0.56
GF Value $2.84
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Arcadia Biosciences Cyclically Adjusted FCF per Share?

Arcadia Biosciences RKDA -18.59% 43 Cyclically Adjusted FCF per Share is $-130.59 as of Mar. 2026. GuruFocus rates RKDA with a GF Score™ of 43/100 and a GF Value™ of $2.84 (Possible Value Trap). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Arcadia Biosciences's adjusted free cash flow per share for the three months ended in Mar. 2026 was $-0.528. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is $-130.59 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2026-08-13), Arcadia Biosciences's current stock price is $0.56. Arcadia Biosciences's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was $-130.59. Arcadia Biosciences's Cyclically Adjusted Price-to-FCF of today is .


Arcadia Biosciences  (NAS:RKDA) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Arcadia Biosciences Cyclically Adjusted FCF per Share Related Terms


Arcadia Biosciences Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Arcadia Biosciences's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Arcadia Biosciences Cyclically Adjusted FCF per Share Chart

Arcadia Biosciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 -223.08 -182.27 -140.45

Arcadia Biosciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -177.46 -161.11 -150.74 -140.45 -130.59

RKDA vs ORISF, ARRT, CIMG: Cyclically Adjusted FCF per Share Comparison

For the Packaged Foods subindustry, Arcadia Biosciences's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Arcadia Biosciences Cyclically Adjusted Price-to-FCF vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Arcadia Biosciences's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Arcadia Biosciences's Cyclically Adjusted Price-to-FCF falls into.


RKDA
43GF Score
Arcadia Biosciences Inc RKDA
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Arcadia Biosciences Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Arcadia Biosciences's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.528/330.2130*330.2130
=-0.528

Current CPI (Mar. 2026) = 330.2130.

Arcadia Biosciences Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 -73.691 241.018 -100.962
201609 -71.909 241.428 -98.353
201612 -76.536 241.432 -104.680
201703 -83.400 243.801 -112.960
201706 -82.792 244.955 -111.608
201709 -44.981 246.819 -60.179
201712 -50.660 246.524 -67.858
201803 -48.182 249.554 -63.755
201806 -52.241 251.989 -68.458
201809 -33.941 252.439 -44.398
201812 -23.800 251.233 -31.282
201903 -34.092 254.202 -44.286
201906 -37.198 256.143 -47.955
201909 -24.828 256.759 -31.931
201912 -25.857 256.974 -33.226
202003 -46.304 258.115 -59.238
202006 -35.403 257.797 -45.348
202009 -26.896 260.280 -34.123
202012 -25.353 260.474 -32.141
202103 -10.908 264.877 -13.599
202106 -11.877 271.696 -14.435
202109 -15.296 274.310 -18.413
202112 -12.159 278.802 -14.401
202203 -8.874 287.504 -10.192
202206 -6.074 296.311 -6.769
202209 -5.490 296.808 -6.108
202212 -3.534 296.797 -3.932
202303 -4.012 301.836 -4.389
202306 -3.533 305.109 -3.824
202309 -2.121 307.789 -2.276
202312 -3.043 306.746 -3.276
202403 -2.366 312.332 -2.501
202406 -1.804 314.175 -1.896
202409 -1.284 315.301 -1.345
202412 -1.618 315.605 -1.693
202503 -1.163 319.799 -1.201
202506 -1.487 322.561 -1.522
202509 -0.187 324.800 -0.190
202512 -0.628 324.054 -0.640
202603 -0.528 330.213 -0.528

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of $-130.59 mean?
Arcadia Biosciences (RKDA) has a Cyclically Adjusted FCF per Share of $-130.59 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Arcadia Biosciences and its competitors.
Is Arcadia Biosciences' Cyclically Adjusted FCF per Share too high?
Arcadia Biosciences' current Cyclically Adjusted FCF per Share is $-130.59. Overall, Arcadia Biosciences has a GF Score™ of 43/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Arcadia Biosciences' Cyclically Adjusted FCF per Share compare to ORISF and ARRT?
Arcadia Biosciences' Cyclically Adjusted FCF per Share of $-130.59 can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Consumer Packaged Goods company?
A good Cyclically Adjusted FCF per Share depends on the Consumer Packaged Goods industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Arcadia Biosciences and its competitors. Arcadia Biosciences's current Cyclically Adjusted FCF per Share is $-130.59. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Arcadia Biosciences stock overvalued right now?
Based on GuruFocus' analysis, Arcadia Biosciences (RKDA) is currently considered Possible Value Trap. The stock's GF Value™ is $2.84, compared to a current price of $0.56 — trading 80.3% below its estimated fair value. The current Cyclically Adjusted FCF per Share is $-130.59. Arcadia Biosciences' overall GF Score™ is 43/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Arcadia Biosciences (RKDA), the current Cyclically Adjusted FCF per Share is $-130.59 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Arcadia Biosciences (RKDA) Overvalued in 2026?

Based on GuruFocus' analysis, Arcadia Biosciences stock appears to be undervalued. The current stock price of $0.56 is trading 80.3% below its estimated GF Value™ of $2.84. GuruFocus considers Arcadia Biosciences to be Possible Value Trap.

Key valuation signals for RKDA:

  • Cyclically Adjusted FCF per Share: $-130.59
  • GF Value™: $2.84 vs. price of $0.56 (80.3% below fair value)
  • GF Score™: 43/100 with 4 warning signs

No single metric tells the full story. See the RKDA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Arcadia Biosciences Business Description

Address 5950 Sherry Lane, Suite 2000, Dallas, TX, USA, 75225
Arcadia Biosciences Inc is a company with science-based approaches to develop high value products and drive innovation in the consumer goods industry. The company has one operating and reportable segment, which derives revenue from the sale of Zola coconut water. The company's consumer brands in the food, beverage, and body care categories, and others. Its products include: Zola Coconut Water, and Agronomic Wheat Traits. Geographically, the company operates in United States, Argentina, India, and Canada. It derives maximum revenue from United States.
43GF Score

Get the complete analysis for RKDA

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.56
Price
$2.84
GF Value